62
Views
429
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5

, , , , , & show all
Pages 8374-8385 | Received 17 May 2004, Accepted 06 Jul 2004, Published online: 27 Mar 2023

REFERENCES

  • Allo, S. N., Carl L. L., and Morgan H. E.. 1992. Acceleration of growth of cultured cardiomyocytes and translocation of protein kinase C. Am. J. Physiol. 263:C319–C325.
  • Antos, C. L., McKinsey T. A., Dreitz M., Hollingsworth L. M., Zhang C. L., Schreiber K., Rindt H., Gorczynski R. J., and Olson E. N.. 2003. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 278:28930–28937.
  • Bowman, J. C., Steinberg S. F., Jiang T., Geenen D. L., Fishman G. I., and Buttrick P. M.. 1997. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. J. Clin. Investig. 100:2189–2195.
  • Braz, J. C., Bueno O. F., De Windt L. J., and Molkentin J. D.. 2002. PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J. Cell Biol. 156:905–919.
  • Braz, J. C., Gregory K., Pathak A., Zhao W., Sahin B., Klevitsky R., Kimball T. F., Lorenz J. N., Nairn A. C., Liggett S. B., Bodi I., Wang S., Schwartz A., Lakatta E. G., DePaoli-Roach A. A., Robbins J., Hewett T. E., Bibb J. A., Westfall M. V., Kranias E. G., and Molkentin J. D.. 2004. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10:248–254.
  • Bush, E., Fielitz J., Melvin L., Martinez-Arnold M., McKinsey T. A., Plichta R., and Olson E. N.. 2004. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc. Natl. Acad. Sci. USA 101:2870–2875.
  • Chawla, S., Vanhoutte P., Arnold F. J., Huang C. L., and Bading H.. 2003. Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J. Neurochem. 85:151–159.
  • Chien, K. R. 1999. Stress pathways and heart failure. Cell 98:555–558.
  • Dequiedt, F., Kasler H., Fischle W., Kiermer V., Weinstein M., Herndier B. G., and Verdin E.. 2003. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 18:687–698.
  • Dunnmon, P. M., Iwaki K., Henderson S. A., Sen A., and Chien K. R.. 1990. Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells. J. Mol. Cell. Cardiol. 22:901–910.
  • Frey, N., and Olson E. N.. 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65:45–79.
  • Grozinger, C. M., Hassig C. A., and Schreiber S. L.. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA 96:4868–4873.
  • Grozinger, C. M., and Schreiber S. L.. 2002. Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol. 9:3–16.
  • Grozinger, C. M., and Schreiber S. L.. 2000. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97:7835–7840.
  • Gschwendt, M., Dieterich S., Rennecke J., Kittstein W., Mueller H. J., and Johannes F. J.. 1996. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase C isoenzymes. FEBS Lett. 392:77–80.
  • Haworth, R. S., Goss M. W., Rozengurt E., and Avkiran M.. 2000. Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation. J. Mol. Cell. Cardiol. 32:1013–1023.
  • Hook, S. S., and Means A. R.. 2001. Ca2+/CaM-dependent kinases: from activation to function. Annu. Rev. Pharmacol. Toxicol. 41:471–505.
  • Iglesias, T., Waldron R. T., and Rozengurt E.. 1998. Identification of in vivo phosphorylation sites required for protein kinase D activation. J. Biol. Chem. 273:27662–27667.
  • Jamora, C., Yamanouye N., Van Lint J., Laudenslager J., Vandenheede J. R., Faulkner D. J., and Malhotra V.. 1999. Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 98:59–68.
  • Jenuwein, T., and Allis C. D.. 2001. Translating the histone code. Science 293:1074–1080.
  • Kao, H. Y., Verdel A., Tsai C. C., Simon C., Juguilon H., and Khochbin S.. 2001. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J. Biol. Chem. 276:47496–47507.
  • Lemonnier, J., Ghayor C., Guicheux J., and Caverzasio J.. 2004. Protein kinase C-independent activation of protein kinase D is involved in BMP-2- induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation. J. Biol. Chem. 279:259–264.
  • Linseman, D. A., Bartley C. M., Le S. S., Laessig T. A., Bouchard R. J., Meintzer M. K., Li M., and Heidenreich K. A.. 2003. Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca2+/calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J. Biol. Chem. 278:41472–41481.
  • Lint, J. V., Rykx A., Vantus T., and Vandenheede J. R.. 2002. Getting to know protein kinase D. Int. J. Biochem. Cell Biol. 34:577–581.
  • Lu, J., McKinsey T. A., Nicol R. L., and Olson E. N.. 2000. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 97:4070–4075.
  • Lu, J., McKinsey T. A., Zhang C. L., and Olson E. N.. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6:233–244.
  • MacLellan, W. R., and Schneider M. D.. 2000. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 62:289–319.
  • McKinsey, T. A., and Olson E. N.. 2004. Cardiac histone acetylation—therapeutic opportunities abound. Trends Genet. 20:206–213.
  • McKinsey, T. A., Zhang C. L., Lu J., and Olson E. N.. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106–111.
  • McKinsey, T. A., Zhang C. L., and Olson E. N.. 2000. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 97:14400–14405.
  • McKinsey, T. A., Zhang C. L., and Olson E. N.. 2001. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol. Cell. Biol. 21:6312–6321.
  • McKinsey, T. A., Zhang C. L., and Olson E. N.. 2002. MEF2: a calcium- dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27:40–47.
  • Miska, E. A., Karlsson C., Langley E., Nielsen S. J., Pines J., and Kouzarides T.. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099–5107.
  • Mochly-Rosen, D., Wu G., Hahn H., Osinska H., Liron T., Lorenz J. N., Yatani A., Robbins J., and Dorn G. W., Jr. 2000. Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. Circ. Res. 86:1173–1179.
  • Molkentin, J. D., Lu J. R., Antos C. L., Markham B., Richardson J., Robbins J., Grant S. R., and Olson E. N.. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215–228.
  • Muth, J. N., Bodi I., Lewis W., Varadi G., and Schwartz A.. 2001. A Ca2+-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 103:140–147.
  • Nishikawa, K., Toker A., Johannes F. J., Songyang Z., and Cantley L. C.. 1997. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272:952–960.
  • Passier, R., Zeng H., Frey N., Naya F. J., Nicol R. L., McKinsey T. A., Overbeek P., Richardson J. A., Grant S. R., and Olson E. N.. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Investig. 105:1395–1406.
  • Rey, O., Reeve J. R., Zhukova E., Sinnett-Smith J., and Rozengurt E.. 2004. G protein-coupled receptor-mediated phosphorylation of the activation loop of protein kinase D: dependence on plasma membrane translocation and protein kinase c epsilon. J. Biol. Chem. 279:34361–34372.
  • Rey, O., Zhukova E., Sinnett-Smith J., and Rozengurt E.. 2003. Vasopressin- induced intracellular redistribution of protein kinase D in intestinal epithelial cells. J. Cell. Physiol. 196:483–492.
  • Roman, B. B., Geenen D. L., Leitges M., and Buttrick P. M.. 2001. PKC-beta is not necessary for cardiac hypertrophy. Am. J. Physiol. Ser. H 280:H2264–H2270.
  • Sadowski, I., Bell B., Broad P., and Hollis M.. 1992. GAL4 fusion vectors for expression in yeast or mammalian cells. Gene 118:137–141.
  • Shirai, Y., and Saito N.. 2002. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J. Biochem. (Tokyo). 132:663–668.
  • Storz, P., Doppler H., and Toker A.. 2004. Protein kinase Cδ selectively regulates protein kinase D-dependent activation of NF-κB in oxidative stress signaling. Mol. Cell. Biol. 24:2614–2626.
  • Storz, P., and Toker A.. 2003. Protein kinase D mediates a stress-induced NF- kappaB activation and survival pathway. EMBO J. 22:109–120.
  • Tsybouleva, N., Zhang L., Chen S., Patel R., Lutucuta S., Nemoto S., DeFreitas G., Entman M., Carabello B. A., Roberts R., and Marian A. J.. 2004. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109:1284–1291.
  • Wang, L., Rolfe M., and Proud C. G.. 2003. Ca2+-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes. Biochem. J. 373:603–611.
  • Wang, A. H., and Yang X. J.. 2001. Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol. Cell. Biol. 21:5992–6005.
  • Zhang, C. L., McKinsey T. A., Chang S., Antos C. L., Hill J. A., and Olson E. N.. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479–488.
  • Zhang, L., Maier S., Dalton N. D., Miyamoto S., Ross J., Jr., Bers D. M., and Brown J. H.. 2003. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92:912–919.
  • Zugaza, J. L., Sinnett-Smith J., Van Lint J., and Rozengurt E.. 1996. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J. 15:6220–6230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.